Treatment of relapsed/refractory chronic lymphocytic leukemia with Zanubrutinib after progressing on other BTK inhibitors
-
Published:2024
Issue:
Volume:21
Page:100459
-
ISSN:2213-0489
-
Container-title:Leukemia Research Reports
-
language:en
-
Short-container-title:Leukemia Research Reports
Author:
Nwankwo NkolikaORCID,
Reddy Aswanth,
Kumar Swarup,
Zafar Maha
Reference12 articles.
1. Diagnosis and Treatment of Chronic Lymphocytic Leukemia: a Review;Shadman;JAMA,2023
2. Chronic lymphocytic leukemia: a clinical review;Nabhan;JAMA,2014
3. Chronic lymphocytic leukemia involvement of the central nervous system: clinical diversity, diagnostic algorithms, and therapeutic challenges;Mihaljevic;Ann Indian Acad Neurol,2018
4. Nikhila Kethireddy, 2019 Evan Boyle, Meredith Haley, Aswanth Reddy, Faripour Forouhar, Jessica Clement, CLL associated giant cell hepatitis, Leuk. Res., https://doi.org/10.1016/j.leukres.2019.05.011.
5. Treatment of chronic lymphocytic leukemia;Burger;N. Engl. J. Med.,2020